Pruritus Market Forecast of 2035
Introduction:
The Global Pruritus Market is witnessing steady growth, driven by the increasing prevalence of chronic skin conditions, rising awareness regarding dermatological disorders, and growing demand for effective treatments to manage persistent itching. Pruritus is commonly associated with conditions such as atopic dermatitis, psoriasis, chronic kidney disease, liver disorders, and other systemic diseases. Increasing adoption of advanced topical and systemic therapies, growing investments in dermatology research, and improvements in diagnostic and treatment approaches are expected to support long-term market growth globally.
Get Free Sample Of This Premium Report:
https://www.decisionsadvisors.com/request-sample/DAR4575
Pruritus Market Insights
Based on Deep Market Insights findings, the Global Pruritus Market was valued at USD 6.3 Billion in 2024 and is estimated to attain USD 8.5 Billion by 2035.
From 2025 to 2035, the market is expected to grow at a CAGR of 2.76%.
Within the Treatment Type category, Topical Treatments dominated in 2024 in terms of market size contribution.
Over the forecast period, Targeted Therapies and Advanced Systemic Treatments are forecasted to deliver the fastest growth due to increasing demand for effective long-term symptom management, advancements in dermatological therapies, and growing focus on treating underlying causes of chronic pruritus.
Other Key Findings
Asia-Pacific is expected to emerge as the fastest-growing regional market during the forecast period, supported by a growing patient population, increasing healthcare expenditure, and rising awareness of dermatological conditions.
• North America accounted for a significant share of the global Pruritus Market, supported by advanced healthcare infrastructure, strong adoption of innovative therapies, and increasing prevalence of chronic dermatological disorders.
• Europe remained a key regional market owing to established healthcare systems and growing demand for advanced dermatology treatments.
• Increasing focus on targeted therapies, improved diagnosis, and development of novel treatments continues to support global market growth.
Report Summary
Report Scope
|
Details |
Information |
|
Base Year for Study |
2024 |
|
Study Period |
2021–2035 |
|
Historical Period |
2021–2024 |
|
Forecast Period |
2025–2035 |
|
Market Size In 2024 |
USD 6.3 Billion |
|
Market Size In 2035 |
USD 8.5 Billion |
|
Largest Region |
North America |
|
Fastest Growing Region |
Asia-Pacific |
|
Units |
Revenue in USD Billion |
|
CAGR |
2.76% (2025–2035) |
Segmentation Covered
|
Category |
Segments |
|
Treatment Type |
1. Topical Treatments 2. Systemic Treatments 3. Phototherapy 4. Others |
|
Disease Type |
1. Atopic Dermatitis 2. Psoriasis 3. Chronic Kidney Disease-Associated Pruritus 4. Cholestatic Pruritus 5. Others |
|
Drug Class |
1. Antihistamines 2. Corticosteroids 3. Calcineurin Inhibitors 4. Opioid Receptor Modulators 5. Others |
|
Distribution Channel |
1. Hospital Pharmacies 2. Retail Pharmacies 3. Online Pharmacies |
|
Region |
1. North America 2. Europe 3. Asia-Pacific 4. Latin America 5. Middle East & Africa |
Report Coverage
Revenue Forecast, Competitive Landscape, Growth Drivers, Industry Trends, Technology Advancements, Regulatory Landscape, Treatment Innovation, Clinical Research Analysis, and Regional Analysis.
Companies
AbbVie Inc., Sanofi, Pfizer Inc., Eli Lilly and Company, Novartis AG, Galderma S.A., LEO Pharma A/S, Regeneron Pharmaceuticals Inc., Amgen Inc., and Johnson & Johnson.
Want detailed insights, forecasts, and competitive analysis?
Check out the full report now:
https://www.decisionsadvisors.com/reports/pruritus-market
Connect with us
- USA - +1 303 800 4326
- APAC - +1 303 800 4326
- sales@sphericalinsights.com